Bruce Kamich, Real Money contributor, took a look at Tilray's chart ahead of earnings.
Here's Kamich's takeaway, "With TLRY going down eight months and many cannabis bulls in retreat or wounded, I would guess (yes, guess) that an upside move is not expected."
But Cramer has his eye on the cannabis industry as a whole.
"I don't like Tilray because I don't like the ownership structure. But cannabis is getting hot again and you might want to buy calls on Tilray? I would rather just accept the fact that I think that Cronos (CRON - Get Report) is good. And Canopy (CGC - Get Report) can turn around, and Aphria (APHA) , which is the one that is run by Irwin Simon is very good and had a very good quarter," said Cramer.
More from Cramer Today
Ask the Expert: The Scariest Thing All Investors Have to Face
Catch Up: Today's Top News Videos Below